Several companies and research institutions are developing potential CAR-T treatments for non-cancer indications, from heart disease to viral infection.
Applications of artificial intelligence (AI) to health care took a major step forward with two noteworthy events in February in the cardiovascular space. In the first case, the U.S. Food and Drug Administration (FDA) approved the marketing of a clinical decision support tool designed to flag signs of a stroke on computed tomography (CT)...